However, like in patient tumors, our study revealed antibody-secreting cells [26] and also B cells, which are potentially able to generate Ado due to their expression of CD39 and CD73 and thus able to suppress the anti-tumor immune response [15]. This evidence concerns the gene ENTPD1 and neoplasm.